Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).

Brujats, A, Villanueva, C. Examining the therapeutic landscape of beta-blockers in portal hypertension. Clinical and Molecular Hepatology. 2024; 30(4)DOI:10.3350/cmh.2024.0144. PMID:38447532. IF:16.900(Q1/1D).

Olivas, P, Soler-Perromat, A, Tellez, L, Carrion, JA, Alvarado-Tapias, E, Ferrusquia-Acosta, J, Lens, S, Guerrero, A, Falga, A, Vizcarra, P, Orts, L, Perez-Campuzano, V, Shalaby, S, Torres, S, Baiges, A, Turon, F, Garcia-Pagan, JC, Garcia-Criado, A, Hernandez-Gea, V. Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient. Jhep Reports. 2024; 6(10)DOI:10.1016/j.jhepr.2024.101170. PMID:39430576. IF:7.500(Q1/2D).

Younossi, Z, Alkhouri, N, Hagström, H, Kim, SU, Crespo, J, Castera, L, Zheng, MH, Treeprasertsuk, S, Shalimer, D, Alswat, K, Fan, JG, Roberts, S, Tsochatzis, E, Dunn, W, Wong, V, Yilmaz, Y, Francque, S, de Oliveira, C, Pessoa, MG, Ekstedt, M, Goh, GBB, Duseja, A, Chan, WK, Fernandez, MIC, Sebastiani, G, Lampertico, P, Alnaamani, K, Valsan, AK, Holleboom, AG, El-Kassas, M, Choudhary, NS, Vessby, J, Singal, A, Kakizaki, S, Pearlman, B, Gunn, N, Cordie, A, Mauricio, D, Kawaguchi, T, Nadeem, R, Shang, Y, Lee, HW, Iruzubieta, P, Liu, WY, Ananchuensook, P, Yang, RX, Zoncapé, M, Dunn, N, Song, SJ, Gadi, Z, Teh, KKJ, Mahadeva, S, Fabian, LG, Cinque, F, D'Ambrosio, R, Friend, E, Poca, M, Colombu, M, Allen, A, Lazarus, J, Lam, B, de Avila, L, Racila, A, Alqahtani, S, Stepanova, M. THE GLOBAL PROFILE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): CLINICAL PRESENTATION, HISTOLOGIC STAGE, NON-INVASIVE TESTS AND MORTALITY FROM THE GLOBAL NAFLD/MASLD REGISTRY. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).